SCHEMBL248622

SCHEMBL248622

CC(=O)OC(C)O[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844777 0.78
SCHEMBL8847825 0.78 SMN1; SMN2 (0.30)
SCHEMBL6141328 0.78
SCHEMBL27640000 0.78
SCHEMBL2359742 0.78
SCHEMBL987906 0.78 TSHR (0.65)
SCHEMBL2958372 0.78 TSHR (0.41)
SCHEMBL2822436 0.76 TSHR (0.39)
SCHEMBL6027918 0.76 MGAM (0.43)
SCHEMBL3895101 0.75 PRKCA (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856747-B1 SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION HOFFMANN LA ROCHE (CH) 2023-07-19 EP claimed
EP-3856747-A1 SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2021-08-04 EP claimed
US-20210221832-A1 SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION HOFFMANN-LA ROCHE INC. (US) 2021-07-22 US claimed
CN-112752762-A Substituted pyridoindoles for the treatment and prevention of bacterial infections 豪夫迈·罗氏有限公司 2021-05-04 CN claimed
WO-2020064661-A1 SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2020-04-02 WO claimed
EP-3607947-A1 COMBINATION OF TAFIA INHIBITOR WITH PLASMINOGEN ACTIVATOR Daiichi Sankyo Company, Limited (JP) 2020-02-12 EP claimed
US-20190117624-A1 THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASES DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-04-25 US claimed
EP-3437641-A1 INFLAMMATORY INTESTINAL DISEASE THERAPEUTIC AGENT DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-02-06 EP claimed
CN-108883094-A Inflammatory bowel Remedies for diseases in association 第三共株式会社 2018-11-23 CN claimed
US-20180243268-A1 COMBINATION OF TAFIa INHIBITOR WITH PLASMINOGEN ACTIVATOR DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-08-30 US claimed
US-6242600-B1 ANTIISCHEMIC AGENTS, ANTICOAGULANTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-05 US claimed
EP-0668272-B1 A process for the production of tetrazolyl compounds TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-07-12 EP claimed
EP-0970071-A1 2-PEPERAZINONE-1-ACETIC ACID DERIVATIVES AND THEIR USE Takeda Chemical Industries, Ltd. (JP) 2000-01-12 EP claimed
WO-1998039324-A1 2-PEPERAZINONE-1-ACETIC ACID DERIVATIVES AND THEIR USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-09-11 WO claimed
EP-0720982-A1 Benzimidazole derivatives, their production and use and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-07-10 EP claimed
US-5496835-A HYPOTENSIVE AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-03-05 US claimed
EP-0603712-A2 Heterocyclic compounds having angiotensin II antagonistic activity and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-06-29 EP claimed
US-4323567-A BACTERICIDES NARISADA MASAYUKI 1982-04-06 US claimed
US-4180571-A Arylmalonamido-1-oxadethiacephalosporins SHIONOGI & CO., LTD. (JP) 1979-12-25 US claimed
US-4138486-A BACTERICIDES SHIONOGI & CO., LTD. (JP) 1979-02-06 US claimed